Gujwell Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 12-07-2024
- Paid Up Capital ₹ 2.00 M
as on 12-07-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.33 Cr
as on 12-07-2024
- Revenue -58.20%
(FY 2022)
- Profit 60.75%
(FY 2022)
- Ebitda 28.96%
(FY 2022)
- Net Worth -41.91%
(FY 2022)
- Total Assets -19.11%
(FY 2022)
About Gujwell Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.33 Cr.
Chintankumar Rajani, Manojbhai Makwana, Laljibhai Vanar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24129GJ2011PTC066452
- Company No.
066452
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Gujwell Biotech Private Limited offer?
Gujwell Biotech Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Fertilizer, Plant Growth Promoters, NP Fertilizer.
Who are the key members and board of directors at Gujwell Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chintankumar Rajani  | Director | 21-Jul-2011 | Current |
| Manojbhai Makwana | Director | 21-Jul-2011 | Current |
| Laljibhai Vanar | Director | 30-Apr-2021 | Current |
| Ashokbhai Dhakan | Director | 30-Apr-2021 | Current |
Financial Performance of Gujwell Biotech.
Gujwell Biotech Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 58.2% decrease. The company also saw a substantial improvement in profitability, with a 60.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 41.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gujwell Biotech?
In 2021, Gujwell Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Feb 2015 | ₹1.58 Cr | Open |
Dena Bank Creation Date: 11 Oct 2012 | ₹7.50 M | Open |
How Many Employees Work at Gujwell Biotech?
Unlock and access historical data on people associated with Gujwell Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gujwell Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gujwell Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
